The U.S. Food and Drug Administration (FDA) has issued a draft guidance for the industry, proposing the use of Minimal... Read more
Category: Uncategorized
EU Approves Otsuka’s Dawnzera as First RNA-Targeted Therapy for HAE
The European Commission (EC) has granted marketing authorization for Otsuka’s Dawnzera (donidalorsen) for the routine prevention of recurrent attacks in... Read more
China’s Clinical Trial Reforms Create Strategic Opportunities for Global Biopharma
China has transitioned from having one of the world's most sluggish drug approval systems to one of the fastest. This... Read more
BD and Ypsomed Strengthen Partnership with New 5.5mL Syringe Variant
Medical technology leaders BD (Becton, Dickinson and Company) and Ypsomed have expanded their ongoing collaboration by introducing a new 5.5mL... Read more
Datwyler Introduces Industry’s First Large-Volume Universal Plunger
Responding to the rise of at-home patient care, Datwyler has launched a first-to-market universal plunger designed for large-volume cartridges of... Read more
Novo Nordisk and Aspect Biosystems Advance Strategic Diabetes Partnership
Novo Nordisk and Aspect Biosystems have entered a new phase of their collaboration aimed at developing curative cell-based medicines for... Read more
CDC Official Downplays Potential Loss of U.S. Measles Elimination Status
Amid expanding measles outbreaks across several states, a top official at the Centers for Disease Control and Prevention (CDC) suggested... Read more
Corvus Shares Surge on Positive Data for Oral Eczema Treatment
On January 20, 2026, Corvus Pharmaceuticals saw its stock price nearly triple following the release of Phase 1 clinical trial... Read more
Johnson & Johnson Eyes $100B Sales Milestone Amid Patent Pressures
In its financial report released January 21, 2026, Johnson & Johnson (J&J) set an ambitious target for the upcoming year,... Read more









